µå·¯±×ÀÎÆ÷¸ÞÀÎ
 

»óº´Äڵ忡 µû¸¥ »óº´¸íÀ» È®ÀÎ ÇϽǼö ÀÖ½À´Ï´Ù.  
»óº´ÄÚµå ÇÑ±Û»óº´¸í ¿µ¹®»óº´¸í
C921 ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´[CML], BCR/ABL-¾ç¼º Chronic myeloid leukemia[CML],BCR/ABL-positive
C921 ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´, Çʶóµ¨ÇÇ¾Æ ¿°»öü ¾ç¼º Chronic myelogenous leukemia, Philadelphia chromosome (Ph1) positive
C921 ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´, t(9:22)(q34:q11) Chronic myelogenous leukemia, t(9:22)(q34:q11)
C921 ¸ð¼¼Æ÷ÀÇ ¹ßÁõÀ» µ¿¹ÝÇÑ ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´ Chronic myelogenous leukemia with crisis of blast cells
C922 ºñÁ¤ÇüÀû ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´[CML], BCR/ABL À½¼º Atypical chronic myeloid leukemia[CML], BCR/ABL-negative
C923 °ñ¼ö¼º À°Á¾ Myeloid sarcoma
C923 ³ì»öÁ¾ Chloroma
C923 °ú¸³±¸¼º À°Á¾ Granulocytic sarcoma
C924 ±Þ¼º Àü°ñ¼ö±¸¼º ¹éÇ÷º´[PML] Acute promyelocytic leukemia[PML]
C924 ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ M3 AML M3
C924 t(15:17) ¹× º¯ÇüÀ» µ¿¹ÝÇÑ ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´Me AML Me with t(15:17) and variants
C925 ±Þ¼º °ñ¼ö´ÜÇÙ±¸¼º ¹éÇ÷º´ Acute myelomonocytic leukemia
C925 ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ M4 AML M4
C925 inv(16) ¶Ç´Â t(16:16)À» µ¿¹ÝÇÑ ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ M4 Eo AML M4 Eo with(16) or t(16::16)
C926 11q23 ÀÌ»óÀ» µ¿¹ÝÇÑ ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ Acute myeloid leukaemia with 11q23-abnormality
C926 MLL-À¯ÀüÀÚ º¯À̸¦ µ¿¹ÝÇÑ ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ Acute myeloid lrukaemia with variation of MLL-gene
C927 ±âŸ °ñ¼ö¼º ¹éÇ÷º´ Other myeloid leukemia
C928 ´Ù¼¼Æ÷°è Çü¼ºÀÌ»óÀ» µ¿¹ÝÇÑ ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ Acute myeloid leukaemia with multi-lineage dysplasia
C929 »ó¼¼ºÒ¸íÀÇ °ñ¼ö¼º ¹éÇ÷º´ Myeloid leukemia, unspecified
C93 ´ÜÇÙ±¸¼º ¹éÇ÷º´ Monocytic leukemia
171  172  173  174  175  176  [177] 178  179  180